Page last updated: 2024-11-06

acetamidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

acetamidine: bovine trypsin inhibitor; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID67171
CHEMBL ID2227684
CHEBI ID38478
MeSH IDM0081302

Synonyms (27)

Synonym
CHEBI:38478 ,
143-37-3
acetimidamide
acetamidin
ch3-c(=nh)-nh2
ethanimidamide
ch3c(=nh)nh2
acetamidine
AKOS000269019
unii-rk19732oqb
rk19732oqb ,
acetamidinium
BBL011922
STL163430
ethanimidamide (9ci)
FT-0621727
acediamine
ethenylamidine
ethanamidine
.alpha.-amino-.alpha.-iminoethane
acetamidine [mi]
OQLZINXFSUDMHM-UHFFFAOYSA-N
actamidine
CHEMBL2227684
acetamidine base
DTXSID00162273
Q27117874

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Studies were conducted using a novel in vitro approach to investigate the efficacy of acetamidine hydrochloride (ACE) and guanidine hydrochloride (GUAN), previously shown to block gramicidin D (GRAM) channels in artificial membranes, in preventing the toxic effects of GRAM in NG108-15 (neuroblastoma x glioma hybrid) cells."( Gramicidin toxicity in NG108-15 cells: protective effects of acetamidine and guanidine.
Doebler, JA, 1999
)
0.77

Pharmacokinetics

ExcerptReferenceRelevance
" The obtained data demonstrate that the amidoxime prodrug shows an improved pharmacokinetic profile with respect to the acetamidine nNOS inhibitor, thus suggesting that it could be a promising lead compound to treat all those pathological conditions in which nNOS activity is dysregulated."( A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential.
Amoroso, R; Cacciatore, I; Clement, B; Di Stefano, A; Fantacuzzi, M; Indorf, P; Maccallini, C; Marinelli, L, 2020
)
0.77

Bioavailability

ExcerptReferenceRelevance
" The most promising prodrug candidates, amidoxime ester 7 and N-hydroxyguanidine ester 8, were subjected to in vivo bioavailability studies."( Zanamivir Amidoxime- and N-Hydroxyguanidine-Based Prodrug Approaches to Tackle Poor Oral Bioavailability.
Clement, B; Hoffmann, A; Kotthaus, J; Müller-Fielitz, H; Raasch, W; Riebling, L; Schade, D; Schmidtke, M, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carboxamidineCompounds having the structure RC(=NR)NR2. The term is used as a suffix in systematic nomenclature to denote the -C(=NH)NH2 group including its carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1082242Phytotoxicity against Gossypium hirsutum (cotton) seedlings assessed as lesions at 50 to 100 ppm after 9 days2011Journal of agricultural and food chemistry, May-11, Volume: 59, Issue:9
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
AID1082240Phytotoxicity against Vitis vinifera seedlings assessed as lesions at 50 to 100 ppm after 9 days2011Journal of agricultural and food chemistry, May-11, Volume: 59, Issue:9
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
AID1082241Phytotoxicity against Zea mays (maize) seedlings assessed as lesions at 50 to 100 ppm after 9 days2011Journal of agricultural and food chemistry, May-11, Volume: 59, Issue:9
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (12.50)18.7374
1990's5 (15.63)18.2507
2000's2 (6.25)29.6817
2010's17 (53.13)24.3611
2020's4 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 56.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index56.87 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index88.74 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (56.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]